(Q26767084)

2

0 references

Fanny Domont

3

0 references

Léa Savey

4

0 references

Anne C Desbois

5

0 references

David Saadoun

Therapeutic advances in infectious disease

6

0 references

language of work or name

English

0 references

publication date

February 2016

0 references

published in

1 reference

Role of the Receptor for the Globular Domain of C1q Protein in the Pathogenesis of Hepatitis C Virus-Related Cryoglobulin Vascular Damage

volume

3

0 references

issue

1

0 references

page(s)

3-14

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

The impact of hepatitis C virus coinfection on HIV-related kidney disease: a systematic review and meta-analysis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Sialadenitis histologically resembling Sjogren syndrome in mice transgenic for hepatitis C virus envelope genes

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Genome-wide association study of hepatitis C virus- and cryoglobulin-related vasculitis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Hepatitis C virus infection in Egyptian children with type 1 diabetes mellitus: A single center study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Life-Threatening Cryoglobulinemic Patients With Hepatitis C: Clinical Description and Outcome of 279 Patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Renal involvement in HCV-related vasculitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Natural history of acute and chronic hepatitis C.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

HCV and lymphoproliferation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Hepatitis C virus-related lymphomagenesis in a mouse model.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

All-cause, liver-related, and non-liver-related mortality among HCV-infected individuals in the general US population

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Persistent expression of the full genome of hepatitis C virus in B cells induces spontaneous development of B-cell lymphomas in vivo

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Changes in quality of life and sexual health are associated with low-dose peginterferon therapy and disease progression in patients with chronic hepatitis C.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Lack of association between hepatitis C infection and chronic kidney disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Increased rate of death related to presence of viremia among hepatitis C virus antibody-positive subjects in a community-based cohort study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Hepatitis C virus infection and the risk of coronary disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Hepatitis C virus infection, mixed cryoglobulinemia and BLyS upregulation: targeting the infectious trigger, the autoimmune response, or both?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Cognitive dysfunction in chronic hepatitis C: a review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

The effects of HCV infection and management on health-related quality of life

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Altered monoaminergic transporter binding in hepatitis C related cerebral dysfunction: a neuroimmunologial condition?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Life-threatening cryoglobulinemia: clinical and immunological characterization of 29 cases.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Emerging evidence of hepatitis C virus neuroinvasion

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Cognitive function in hepatitis C patients with advanced fibrosis enrolled in the HALT-C trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Effect of hepatitis C virus infection on the risk of non-Hodgkin's lymphoma: a meta-analysis of epidemiological studies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

B-cell non-Hodgkin's lymphoma and hepatitis C virus infection: a systematic review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Hepatitis C infection and the patient with end-stage renal disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Hepatitis C virus infection mimicking primary Sjögren syndrome. A clinical and immunologic description of 35 cases

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Extrahepatic manifestations of HCV infection: facts and controversies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Cryoglobulinaemia and rheumatic manifestations in patients with hepatitis C virus infection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Association of diabetes mellitus and chronic hepatitis C virus infection.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Triple antiviral therapy in hepatitis C virus infection with or without mixed cryoglobulinaemia: a prospective, controlled pilot study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Active at night, sleepy all day--sleep disturbances in patients with hepatitis C virus infection

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Interferon-based therapy reduces risk of stroke in chronic hepatitis C patients: a population-based cohort study in Taiwan.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Hepatitis C virus persistence in human hematopoietic cells injected into SCID mice

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Infection of peripheral mononuclear blood cells by hepatitis C virus

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis C.

31 May 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Prevalence of monoclonal gammopathies in patients with hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Hepatitis C and carotid atherosclerosis: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

HCV infection and the incidence of CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Effects of anti-viral therapy and HCV clearance on cerebral metabolism and cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Insulin resistance impairs sustained virological response rate to pegylated interferon plus ribavirin in HIV-hepatitis C virus-coinfected patients: HOMAVIC-ANRS HC02 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Impact of treatment on extra hepatic manifestations in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Hepatitis C virus infection and the prevalence of renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Extrahepatic manifestations of hepatitis C among United States male veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Hepatitis C virus and atherosclerosis in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Hepatitis C virus RNA in the bone marrow of patients with mixed cryoglobulinemia and in subjects with noncryoglobulinemic chronic hepatitis type C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Association between mixed cryoglobulinemia, translocation (14;18), and persistence of occult HCV lymphoid infection after treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Association between persistent lymphatic infection by hepatitis C virus after antiviral treatment and mixed cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Depression and anxiety in patients with hepatitis C: prevalence, detection rates and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Viral hepatitis and proteinuria in an area endemic for hepatitis B and C infections: another chain of link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Fatigue and health-related quality of life (HRQL) in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Viral elimination reduces incidence of malignant lymphoma in patients with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Hepatitis C Virus and Non-Hodgkin’s Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

The B lymphocyte stimulator receptor-ligand system in hepatitis C virus-induced B cell clonal disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Association of hepatitis C and B virus infection with CKD in an endemic area in Taiwan: a cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Elevated Serum Levels of Osteopontin in HCV-Associated Lymphoproliferative Disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Investigating health-related quality of life, mood and neuropsychological test performance in a homogeneous cohort of Irish female hepatitis C patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Adherence to treatment and quality of life during hepatitis C therapy: a prospective, real-life, observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Myocardial injury in patients with chronic hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Pegylated-interferon plus ribavirin for HCV-positive indolent non-Hodgkin lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Prevalence and significance of neurocognitive dysfunction in hepatitis C in the absence of correlated risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Increased Mortality Among Persons Infected With Hepatitis C Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Fatigue in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Role of matrix metalloproteinases, proinflammatory cytokines, and oxidative stress-derived molecules in hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Involvement of chemokines and type 1 cytokines in the pathogenesis of hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Using rituximab plus fludarabine and cyclophosphamide as a treatment for refractory mixed cryoglobulinemia associated with lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Rituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Antiviral therapy for hepatitis C virus--associated mixed cryoglobulinemia vasculitis: a long-term followup study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Hepatitis C virus-associated B-cell proliferation--the role of serum B lymphocyte stimulator (BLyS/BAFF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Atherosclerosis risk in HIV-infected patients: the influence of hepatitis C virus co-infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Presentation and prognosis of cardiac involvement in hepatitis C virus-related vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Improved cognitive function as a consequence of hepatitis C virus treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Relationship between hepatitis C and chronic kidney disease: results from the Third National Health and Nutrition Examination Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Clonal B cell populations in the blood and liver of patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

T(14;18) translocation in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Carotid atherosclerosis and chronic hepatitis C: A prospective study of risk associations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2049936115585942

Early effect of peginterferon alpha-2b plus ribavirin treatment on blood pressure and insulin resistance in patients with chronic hepatitis C.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Central nervous system involvement in hepatitis C virus cryoglobulinemia vasculitis: a multicenter case-control study using magnetic resonance imaging and neuropsychological tests.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Longterm course of mixed cryoglobulinemia in patients infected with hepatitis C virus

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Hepatitis C virus infection: a new bridge between hematologists and gastroenterologists?

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735500

Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis

28 November 2018

1 reference

12 December 2020

Relationship between hepatitis C and microalbuminuria: results from the NHANES III

1 reference

12 December 2020

EASL Clinical Practice Guidelines: management of hepatitis C virus infection

1 reference

12 December 2020

Rituximab as first-line and maintenance therapy for patients with indolent non-hodgkin's lymphoma

1 reference

12 December 2020

Frequency of bcl-2 rearrangement in patients with mixed cryoglobulinemia and HCV-positive liver diseases

1 reference

12 December 2020

Identifiers

DOI

10.1177/2049936115585942

1 reference

1 reference

1 reference

PubMed publication ID

26862398

1 reference